FilingReader Intelligence
Huahai Pharma completes private placement, adjusts convertible bond price
March 31, 2025 at 12:46 PM UTC•By FilingReader AI
Zhejiang Huahai Pharmaceutical (SSE:600521) announced the successful completion of its private placement of 41,152,263 shares at CNY14.58 per share, raising total gross proceeds of CNY599,999,994.54. The net proceeds, after deducting issuance expenses, amount to CNY582,319,365.51 and will be allocated to the company's pharmaceutical manufacturing project and to supplement working capital.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Supplementary Source Documents
Zhejiang Huahai Pharmaceutical Co., Ltd.'s announcement on the adjustment of the conversion price of "Huahai Convertible Bonds" due to the issuance of shares to specific objects and the suspension and resumption of tradingMarch 26, 2025 at 09:16 AM UTC
Zhejiang Huahai Pharmaceutical Co., Ltd.'s listing announcement on the issuance of shares to specific objectsMarch 26, 2025 at 09:16 AM UTC
News Alerts
Get instant email alerts when Zhejiang Huahai Pharmaceutical publishes news
Free account required • Unsubscribe anytime